Results 81 to 90 of about 7,788 (192)

ANGIOGRAPHIC SMOKESTACK LEAKAGE NOT ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY

open access: yes, 2022
PURPOSE: To report a series of cases with smokestack leakage on fundus fluorescein angiography outside the clinical setting of central serous chorioretinopathy. METHODS: A multicenter, observational retrospective case series evaluating fundus fluorescein
Chang, Luke   +4 more
core   +1 more source

Shallow Anterior Chamber in a Severe Case of Unilateral Acute Central Serous Retinal Detachment

open access: yesCase Reports in Ophthalmology, 2017
Background: Atypical serous chorioretinopathy can present with symptoms similar to those of other pachychoroid diseases; however, a proper differential diagnosis will prevent unnecessary intensive treatments.
Ahmet Colakoglu, Banu Cosar
doaj   +1 more source

Transpupillary thermotherapy for atypical central serous chorioretinopathy

open access: yes, 2012
Ryosuke Kawamura1,2, Hidenao Ideta1, Hideyuki Hori1, Kenya Yuki2, Tsuyoshi Uno1, Tatsurou Tanabe1, Kazuo Tsubota2, Tsutomu Kawasaki11Ideta Eye Hospital, Kumamoto, Japan; 2Keio University, School of Medicine, Department of Ophthalmology, Tokyo ...
Kawasaki T   +7 more
core  

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy

open access: yes, 2018
Danial Mohabati,1,2 Elon HC van Dijk,1 Thomas J van Rijssen,1 Eiko K de Jong,3 Myrte B Breukink,3 Jose P Martinez-Ciriano,4 Greet Dijkman,1 Carel B Hoyng,3 Sascha Fauser,5 Suzanne Yzer,4 Camiel JF Boon1,6 1Department of Ophthalmology, Leiden University ...
Breukink MB   +10 more
core  

Central serous chorioretinopathy [PDF]

open access: yesBritish Journal of Ophthalmology, 2003
What is the eye telling us? Central serous chorioretinopathy (CSC) has captured the attention of physicians for nearly 150 years. Psychic stress and behavioural traits were originally described as potential contributing factors in the development of this disorder by Horniker in 1927.1 Since that time, many others have attempted to better define this ...
openaire   +1 more source

Atypical Presentation of Choroidal Folds: Steroid-induced Central Serous Chorioretinopathy-like Maculopathy

open access: yesTürk Oftalmoloji Dergisi, 2019
This article reports a case of choroidal folds and central serous chorioretinopathy-like maculopathy induced by corticosteroid treatment. The patient was a 70-year-old woman who presented with decreased visual acuity in the right eye.
Cumali Değirmenci   +3 more
doaj   +1 more source

Central serous chorioretinopathy: a pathogenetic model

open access: yes, 2011
Antonio Caccavale1, Filippo Romanazzi1, Manuela Imparato1, Angelo Negri2, Anna Morano3, Fabio Ferentini21Department of Ophthalmology, Neuropthalmology and Ocular Immunology Service, 2Department of Ophthalmology, Hospital “C.
et al   +3 more
core  

Long-term Eplerenone treatment in chronic central serous chorioretinopathy: effects on affected and fellow eye

open access: yes, 2023
Purpose: Purpose of this study is to assess long-term morpho-functional retinal and choroidal changes both in affected and in fellow eyes with chronic central serous chorioretinopathy (cCSC) in response to continuous oral EPL treatment by means of ...
Giacomo Boscia   +8 more
core  

Oral eplerenone for treatment of bullous retinal detachment secondary to chronic central serous retinopathy

open access: yesKerala Journal of Ophthalmology, 2017
The bullous variant is a rare manifestation of central serous retinopathy (CSR). Multiple therapeutic approaches have been described to treat these bullous detachments which mainly involve laser photocoagulation or surgical drainage. Here, we demonstrate
Prachi Abhishek Dave, Jay Chhablani
doaj   +1 more source

Photodynamic Therapy and Central Serous Chorioretinopathy

open access: yes, 2012
Central serous chorioretinopathy is a common acquired maculopathy. Multiple studies showed that photodynamic therapy is useful treatment for acute and chronic central serous chorioretinopathy.
Jurate Balciuniene, Vilma   +3 more
core  

Home - About - Disclaimer - Privacy